Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study

被引：0
|
作者：
Takashi Wada
Masaya Inagaki
Toru Yoshinari
Ryuji Terata
Naoko Totsuka
Miki Gotou
Gaia Hashimoto
机构：
[1] Kanazawa University,Department of Nephrology and Laboratory Medicine
[2] Mitsubishi Tanabe Pharma Corporation,Data Science Department, Ikuyaku. Integrated Value Development Division
[3] Mitsubishi Tanabe Pharma Corporation,Clinical Research and Development II Department, Ikuyaku. Integrated Value Development Division
来源：
Clinical and Experimental Nephrology | 2021年 / 25卷
关键词：
Diabetic nephropathy; Diabetic kidney disease; Dose-finding study; Fibrosis; Mineralocorticoid receptor antagonists; Apararenone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：120 / 130
页数：10
相关论文
共 50 条
  • [21] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 1-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
    Deodhar, Atul
    van der Heijde, Desiree
    Sieper, Joachim
    Van den Bosch, Filip
    Maksymowych, Walter
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina D.
    Song, In-Ho
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [22] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study with an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis (RG)
    Zuraw, Qing
    Cui, Xiaoming
    Fang, Jianmin
    ANNALS OF NEUROLOGY, 2024, 96 : S86 - S87
  • [23] Safety and efficacy of paliperidone extendedrelease in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
    Zhang, Hongyan
    Li, Huafang
    Liu, Yanning
    Wu, Cathy
    Wu, Qingqi
    Nuamah, Isaac
    Shi, Jianguo
    Xie, Shiping
    Wang, Gang
    Gopal, Srihari
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 69 - 77
  • [24] Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Kamphuis, Jeanine
    Spijker, Jan
    van der Meij, Annemarie
    van Asselt, Antoinette D. I.
    aan het Rot, Marije
    Schoevers, Robert A.
    MOLECULAR PSYCHIATRY, 2024, 29 (09) : 2657 - 2665
  • [25] Intragastric Injection of Botulinum Toxin a to Treat Obesity: Mechanism of Action and a Randomized, Double-Blind, Placebo-Controlled Phase II Trial With Open-Label Extension Study
    Chen, Duan
    Olsen, Magnus K.
    Strommen, Magnus
    Johannessen, Helene
    Bjoru, Hege T.
    Salater, Sissel
    Johnsen, Gjermund
    Marvik, Ronald
    Zhao, Chun-Mei
    Kulseng, Baard
    GASTROENTEROLOGY, 2016, 150 (04) : S823 - S823
  • [26] Buprenorphine Transdermal System in Adults With Chronic Low Back Pain: A Randomized, Double-Blind, Placebo-Controlled Crossover Study, Followed by an Open-Label Extension Phase
    Gordon, Allan
    Callaghan, Denis
    Spink, Donald
    Cloutier, Christian
    Dzongowski, Peter
    O'Mahony, William
    Sinclair, Duncan
    Rashiq, Saifudin
    Buckley, Norm
    Cohen, Geoffrey
    Kim, James
    Boulanger, Aline
    Piraino, Paula S.
    Eisenhoffer, John
    Harsanyi, Zoltan
    Darke, Andrew C.
    Michalko, Kenneth J.
    CLINICAL THERAPEUTICS, 2010, 32 (05) : 844 - 860
  • [27] Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study
    Seok, Joon
    Koh, Young Gue
    Hong, Jun Ki
    Yun, So Hye
    Kim, Da Hye
    Son, Hyung Seok
    Choi, Sun Young
    Yoo, Kwang Ho
    Lee, Yang Won
    Kim, Beom Joon
    DERMATOLOGIC SURGERY, 2024, 50 (06) : 527 - 533
  • [28] Evaluation of non-motor symptoms in opicapone treated Parkinson's disease patients: results from a double-blind, randomized, placebo-controlled study and open-label extension
    Oliveira, C.
    Lees, A.
    Ferreira, J.
    Lopes, N.
    Costa, R.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 191 - 191
  • [29] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Lesley M. Arnold
    Kenneth N. Schikler
    Lucinda Bateman
    Tahira Khan
    Lynne Pauer
    Pritha Bhadra-Brown
    Andrew Clair
    Marci L. Chew
    Joseph Scavone
    Pediatric Rheumatology, 14
  • [30] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Arnold, Lesley M.
    Schikler, Kenneth N.
    Bateman, Lucinda
    Khan, Tahira
    Pauer, Lynne
    Bhadra-Brown, Pritha
    Clair, Andrew
    Chew, Marci L.
    Scavone, Joseph
    PEDIATRIC RHEUMATOLOGY, 2016, 14
12345